| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dustin C Lee, Nicolas J Schlienz, Erica N Peters, Robert H Dworkin, Dennis C Turk, Eric C Strain, Ryan Vandre. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and alcohol dependence. vol 194. 2019-05-01. PMID:30530238. |
the purpose of this systematic review is to: 1) identify and characterize approaches for measuring cannabis use in existing cud intervention trials, including abstinence, frequency and quantity of use, and 2) summarize measures used to assess treatment efficacy in other outcome domains (e.g., cannabis use severity, psychosocial functioning, cannabis withdrawal), and provide a platform for future research to evaluate which outcome measures are most likely to reflect treatment efficacy and clinically significant improvement in other outcome domains. |
2019-05-01 |
2023-08-13 |
Not clear |
| Katherine T Foster, Brooke J Arterberry, William G Iacono, Matt McGue, Brian M Hick. Psychosocial functioning among regular cannabis users with and without cannabis use disorder. Psychological medicine. vol 48. issue 11. 2019-04-12. PMID:29173210. |
only about 30% of regular cannabis users develop cannabis use disorder (cud), but it is unclear if individuals who use cannabis regularly without ever developing cud experience notable psychosocial impairment across the lifespan. |
2019-04-12 |
2023-08-13 |
Not clear |
| Katherine T Foster, Brooke J Arterberry, William G Iacono, Matt McGue, Brian M Hick. Psychosocial functioning among regular cannabis users with and without cannabis use disorder. Psychological medicine. vol 48. issue 11. 2019-04-12. PMID:29173210. |
therefore, psychosocial functioning was compared across regular cannabis users with or without cud and a non-user control group during adolescence (age 17; early risk) and young adulthood (ages 18-25; peak cud prevalence). |
2019-04-12 |
2023-08-13 |
Not clear |
| Beth Han, Wilson M Compton, Christopher M Jones, Carlos Blanc. Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-2014. The Journal of clinical psychiatry. vol 78. issue 9. 2019-04-03. PMID:28686820. |
to examine trends in past-year cannabis use (cu) and cannabis use disorders (cud) among youth in the united states, when related changes began, and factors associated with these changes. |
2019-04-03 |
2023-08-13 |
Not clear |
| Jacquelyn L Meyers, Carolyn E Sartor, Kimberly B Werner, Karestan C Koenen, Bridget F Grant, Deborah Hasi. Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? Psychological medicine. vol 48. issue 9. 2019-03-20. PMID:29310741. |
this study examined variation by race/ethnicity and gender in associations of alcohol (aud), cannabis (cud), and tobacco (tud) use disorders with three types of childhood interpersonal violence (cipv): physical abuse, sexual abuse, and witnessing parental violence. |
2019-03-20 |
2023-08-13 |
Not clear |
| Richard J Macatee, Brian J Albanese, Natania A Crane, Sarah A Okey, Jesse R Cougle, Norman B Schmid. Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 32. issue 8. 2019-02-25. PMID:30407026. |
cannabis use is prevalent but only a minority of regular users develop cannabis use disorder (cud); thus, cud risk identification among current cannabis users is vital for targeted intervention development. |
2019-02-25 |
2023-08-13 |
Not clear |
| Richard J Macatee, Brian J Albanese, Natania A Crane, Sarah A Okey, Jesse R Cougle, Norman B Schmid. Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 32. issue 8. 2019-02-25. PMID:30407026. |
stress-elicited enhancement of conflict-monitoring neural activity during response inhibition may reflect an adaptive neural response among cannabis users with high di that protects against cud in this at-risk group. |
2019-02-25 |
2023-08-13 |
Not clear |
| Michael J Mason, Nikola M Zaharakis, Matthew Moore, Aaron Brown, Claudia Garcia, Ashlie Seibers, Chelsea Stephen. Who responds best to text-delivered cannabis use disorder treatment? A randomized clinical trial with young adults. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 32. issue 7. 2019-01-21. PMID:30265057. |
young adults ages 18 to 25 have the highest percentage (5%) of cannabis use disorder (cud) among all age groups, and are the least likely to receive treatment compared with other age groups. |
2019-01-21 |
2023-08-13 |
human |
| Hayley Treloar Padovano, Robert Mirand. Subjective cannabis effects as part of a developing disorder in adolescents and emerging adults. Journal of abnormal psychology. vol 127. issue 3. 2019-01-09. PMID:29672090. |
study aims were to (a) characterize momentary changes in several subjective states (i.e., stimulation, sedation, tension, craving, and high) when not using, just before cannabis use, and after use, and (b) evaluate whether cannabis responses varied with cannabis use disorder (cud) severity or across the transition from adolescence to emerging adulthood in a correlational manner. |
2019-01-09 |
2023-08-13 |
human |
| Michael J Wesley, Philip M Westgate, William W Stoops, Thomas H Kelly, Lon R Hays, Joshua A Lil. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users. Experimental and clinical psychopharmacology. vol 26. issue 3. 2018-12-31. PMID:29863387. |
no medications are approved for cannabis use disorder (cud). |
2018-12-31 |
2023-08-13 |
human |
| Michael J Wesley, Philip M Westgate, William W Stoops, Thomas H Kelly, Lon R Hays, Joshua A Lil. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users. Experimental and clinical psychopharmacology. vol 26. issue 3. 2018-12-31. PMID:29863387. |
these human laboratory results from a sample of nontreatment-seeking cannabis users do not support the potential efficacy of 12 mg of tiagabine as a stand-alone pharmacotherapy for cud. |
2018-12-31 |
2023-08-13 |
human |
| Kristen R Trexler, Sara R Nass, Molly S Crowe, Joshua D Gross, Margaret S Jones, Austin W McKitrick, David P Siderovski, Steven G Kinse. Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice. Drug and alcohol dependence. vol 191. 2018-11-27. PMID:30071445. |
a subset of cannabis users develop some degree of cannabis use disorder (cud). |
2018-11-27 |
2023-08-13 |
mouse |
| Andrea H Weinberger, Lauren R Pacek, Melanie M Wall, Michael J Zvolensky, Jan Copeland, Sandro Galea, Shadi Nahvi, Scott J Moeller, Deborah S Hasin, Renee D Goodwi. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016. Drug and alcohol dependence. vol 191. 2018-11-27. PMID:30077055. |
cannabis use disorder (cud) occurs among a small subset of cannabis users and may impact cigarette use. |
2018-11-27 |
2023-08-13 |
Not clear |
| Nathan A Kimbrel, Eric C Meyer, Bryann B DeBeer, Suzy B Gulliver, Sandra B Morissett. The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders. Suicide & life-threatening behavior. vol 48. issue 2. 2018-11-20. PMID:28295524. |
the objective of this study was to assess the association between cannabis use disorder (cud) and self-injury among veterans. |
2018-11-20 |
2023-08-13 |
Not clear |
| Rachel A Rabin, Karolina Kozak, Konstantine K Zakzanis, Gary Remington, Cristiana Stefan, Alan J Budney, Tony P Georg. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophrenia research. vol 194. 2018-11-13. PMID:28506704. |
cannabis use disorders (cud) are common in schizophrenia (~25%) compared to the general population (~3%). |
2018-11-13 |
2023-08-13 |
Not clear |
| Susan Whitfield-Gabrieli, Adina S Fischer, Angela M Henricks, Jibran Y Khokhar, Robert M Roth, Mary F Brunette, Alan I Gree. Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation. Schizophrenia research. vol 194. 2018-11-13. PMID:28823723. |
nearly half of patients with schizophrenia (scz) have co-occurring cannabis use disorder (cud), which has been associated with decreased treatment efficacy, increased risk of psychotic relapse, and poor global functioning. |
2018-11-13 |
2023-08-13 |
Not clear |
| Cristina Casajuana, Hugo López-Pelayo, Laia Miquel, María Mercedes Balcells-Oliveró, Joan Colom, Antoni Gua. Quantitative Criteria to Screen for Cannabis Use Disorder. European addiction research. vol 24. issue 3. 2018-10-22. PMID:29949807. |
this study proposes a preliminary quantitative cutoff criterion to screen for cannabis use disorder (cud). |
2018-10-22 |
2023-08-13 |
Not clear |
| Lindsay M Squeglia, Rachel L Tomko, Nathaniel L Baker, Erin A McClure, George A Book, Kevin M Gra. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug and alcohol dependence. vol 185. 2018-09-18. PMID:29413434. |
this secondary analysis from the national drug abuse treatment clinical trials network examined the effects of nac versus placebo on alcohol use among participants with cannabis use disorder (cud) enrolled in a 12-week, multi-site cannabis cessation trial. |
2018-09-18 |
2023-08-13 |
human |
| Gregory L Sahlem, Nathaniel L Baker, Mark S George, Robert J Malcolm, Aimee L McRae-Clar. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. The American journal of drug and alcohol abuse. vol 44. issue 1. 2018-09-14. PMID:28806104. |
cannabis use disorder (cud) is a common condition with few treatments. |
2018-09-14 |
2023-08-13 |
Not clear |
| Mallory Loflin, Kimberly Babson, Kendall Browne, Marcel Bonn-Mille. Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users. The American journal of drug and alcohol abuse. vol 44. issue 1. 2018-09-14. PMID:29058471. |
the cannabis use disorders identification test-revised (cudit-r) is an 8-item measure used to screen for cannabis use disorders (cud). |
2018-09-14 |
2023-08-13 |
Not clear |